Armistice Capital, LLC Oramed Pharmaceuticals Inc. Transaction History

Armistice Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$2.95 - $3.64 $1.6 Million - $1.98 Million	-542,944 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$3.0 - $4.94 $243,168 - $400,416	-81,056 Reduced 12.99%	542,944 $1.63 Million
Q3 2018 Nov 14, 2018	BUY	$4.64 - $7.11 $2.9 Million - $4.44 Million	624,000 New	624,000 $3.04 Million

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.